Results
448
Companies with a Value score of at least 3, ordered by Value score
448 companies
Merck KGaA
Market Cap: US$48.0b
Operates as a science and technology company in Germany.
MKGA.F
US$124.46
7D
-6.8%
1Y
-30.3%
Amphastar Pharmaceuticals
Market Cap: US$1.2b
A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
AMPH
US$24.56
7D
-5.5%
1Y
-39.9%
Regeneron Pharmaceuticals
Market Cap: US$53.9b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
REGN
US$509.72
7D
-2.5%
1Y
-52.1%
Merck
Market Cap: US$198.5b
Operates as a healthcare company worldwide.
MRK
US$79.06
7D
-2.3%
1Y
-40.5%
United Therapeutics
Market Cap: US$13.1b
A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
UTHR
US$290.75
7D
0.8%
1Y
-8.8%
Exact Sciences
Market Cap: US$10.0b
Provides cancer screening and diagnostic test products in the United States and internationally.
EXAS
US$53.02
7D
-0.5%
1Y
26.4%
Anika Therapeutics
Market Cap: US$151.9m
A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.
ANIK
US$10.59
7D
-4.7%
1Y
-59.1%
Jazz Pharmaceuticals
Market Cap: US$6.5b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$107.51
7D
-1.9%
1Y
-2.1%
Bristol-Myers Squibb
Market Cap: US$95.4b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
US$46.86
7D
-3.7%
1Y
11.0%
Decibel Cannabis
Market Cap: US$40.4m
An integrated cannabis company, engages in the cannabis cultivation in Canada.
DBCC.F
US$0.05
7D
-7.8%
1Y
3.7%
Teva Pharmaceutical Industries
Market Cap: US$19.4b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$16.95
7D
-3.1%
1Y
2.8%
BeOne Medicines
Market Cap: US$29.3b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$247.08
7D
-6.6%
1Y
55.2%
Bio-Rad Laboratories
Market Cap: US$6.5b
Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.
BIO
US$236.74
7D
2.2%
1Y
-16.6%
ANI Pharmaceuticals
Market Cap: US$1.3b
A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
ANIP
US$65.56
7D
2.0%
1Y
4.4%
Evolus
Market Cap: US$598.3m
A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.
EOLS
US$9.28
7D
-6.8%
1Y
-11.7%
ICON
Market Cap: US$11.6b
A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.
ICLR
US$146.48
7D
-0.4%
1Y
-53.8%
Perrigo
Market Cap: US$3.6b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PRGO
US$26.50
7D
-0.7%
1Y
1.5%
Sanofi
Market Cap: US$101.4b
A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.
SNYN.F
US$94.76
7D
-6.6%
1Y
-1.4%
Amneal Pharmaceuticals
Market Cap: US$2.5b
A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.
AMRX
US$7.82
7D
-3.6%
1Y
19.4%
Trulieve Cannabis
Market Cap: US$903.9m
Operates as a cannabis retailer.
TCNN.F
US$3.45
7D
-6.1%
1Y
-65.3%
Evotec
Market Cap: US$1.2b
Operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.
EVO
US$3.76
7D
-9.0%
1Y
-18.3%
Halozyme Therapeutics
Market Cap: US$6.5b
A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.
HALO
US$52.81
7D
-2.1%
1Y
1.4%
Biogen
Market Cap: US$18.6b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIB
US$127.04
7D
-3.1%
1Y
-43.9%
Royalty Pharma
Market Cap: US$19.6b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$34.86
7D
-0.7%
1Y
28.6%
Organon
Market Cap: US$2.5b
Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.
OGN
US$9.75
7D
-4.3%
1Y
-53.8%
Viatris
Market Cap: US$10.4b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$8.87
7D
-1.3%
1Y
-15.3%
Pacira BioSciences
Market Cap: US$1.1b
Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.
PCRX
US$24.23
7D
-0.5%
1Y
-16.6%
Curaleaf Holdings
Market Cap: US$818.0m
Produces and distributes cannabis products in the United States and internationally.
CURL.F
US$0.80
7D
-4.9%
1Y
-80.6%
Avantor
Market Cap: US$9.2b
Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
AVTR
US$13.57
7D
1.0%
1Y
-39.7%
Cresco Labs
Market Cap: US$272.3m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.
CRLB.F
US$0.43
7D
-12.8%
1Y
-74.3%
AVITA Medical
Market Cap: US$137.0m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$5.17
7D
-5.5%
1Y
-35.9%
Bayer
Market Cap: US$26.2b
Operates as a life science company worldwide.
BAYZ.F
US$31.34
7D
-1.5%
1Y
10.2%
Tilray Brands
Market Cap: US$359.8m
A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.
TLRY
US$0.36
7D
-14.8%
1Y
-78.3%
UroGen Pharma
Market Cap: US$675.5m
Engages in the development and commercialization of solutions for urothelial and specialty cancers.
URGN
US$14.65
7D
2.2%
1Y
-16.1%
Cytek Biosciences
Market Cap: US$373.6m
A cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.
CTKB
US$2.95
7D
-10.6%
1Y
-47.3%
High Tide
Market Cap: US$248.0m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
US$2.22
7D
0%
1Y
-2.2%